Found 14 matching trials
4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy
PHASE2The purpose of this study is to see if the study drug 4-aminopyridine (4-AP...
Location
University of Rochester Medical Center
Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis
PHASE2The goal of this interventional double blind, randomized placebo controlled...
Location
Multiple Locations
Study of Oral Fampridine-SR in Multiple Sclerosis
PHASE3To assess the safety and efficacy of 10 milligram (mg) twice a day (b.i.d.)...
Location
University of Alabama
A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
PHASE4Determine whether dalfampridine (Ampyra) can improve visual function in pat...
Location
Neuro-Ophthalmologic Associates, PC
Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients
PHASE2The purpose of this study is to assess whether 4-AP (Dalfampridine-ER, Ampy...
Location
Columbia University Medical Center
Dalfampridine for Imbalance in Multiple Sclerosis
PHASE2Dalfampridine is a new medication that was FDA approved in 2010 to improve ...
Location
Oregon Health and Science University
A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis
PHASE4A randomized placebo controlled double-blind cross-over trial of Dalfamprid...
Location
MS Center at Evergreen
Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
PHASE2Transverse myelitis (TM) is an inflammatory disorder of the spinal cord tha...
Location
Johns Hopkins University
Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients
PHASE4Phase 4, single center, double-blind, placebo-controlled study. Fifty (50) ...
Location
Clinique Neuro-Outaouais
Dalfampridine and Gait in Spinocerebellar Ataxias
NAInvestigators expect there will be improvement in walking speed and steadin...
Location
University of Florida